Combination Therapy of an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein and Peroxisome Proliferator-Activated Receptor γ
Agonist in Diabetic Rat
Figure 1
Changes in food intake (a) and body weight (b) in control group, JTT-130 treatment group, pioglitazone treatment group, and combination group. Data represent mean values ± standard deviation (). *P < 0.05, **P < 0.01, significantly different from control group. #P < 0.05, significantly different from JTT-130 treatment group.
